Go to deals
Healthcare | Private Equity

Igyxos S.A. has completed a Series A fundraising

Igyxos S.A. has completed a US$8.4 million fundraising as part of a Series A funding led by Bpifrance through its FABS Fund, with participation from the Go Capital Amorçage II and Loire Valley Invest Funds and by the Emergence Innovation II. This will allow the founder Marie Christine Maurel and Professor René Frydman, joined by Pierre-Henry Longeray (ex Merck Serono) as CEO, to pursue the proof of concept in human clinical practice.

Based in Nouzilly, France, biotechnology startup Igyxos is developing a new treatment for female and male infertility that works by shifting hormonal imbalances with a new method using monoclonal antibodies.

Oaklins’ team in France advised Igyxos on a "dual-track" project that allowed them to validate with the industry both scientific and therapeutic interest of its drug candidate based on the use of monoclonal antibodies to improve the treatment of female and male infertility.

“This fundraising of US$8.4 million associated with the arrival of Pierre-Henry Longeray as CEO, and the support and expertise of Professor René Frydman, who has been with us from the beginning, gives us real hope to see the treatment developed by Igyxos successfully reach the market. We thank Oaklins’ team in France for their efficient and strong support.”

Marie-Christine Maurel

CSO and Founder, Igyxos, S.A.

Talk to the deal team

Thibaut de Monclin

Managing Partner
Paris, France
Oaklins France

Related deals

TEAM Safety Services Limited has been acquired by Vadella Group
Private Equity | Business Support Services

TEAM Safety Services Limited has been acquired by Vadella Group

TEAM Safety Services Limited, a leading UK-based health, safety and fire safety consultancy, has been acquired by Vadella Group, a specialist provider of inspection-led compliance services for the built environment.

Learn more
MEDIK Hospital Design Group has been acquired by STERIS
Construction & Engineering Services | Healthcare

MEDIK Hospital Design Group has been acquired by STERIS

The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc. Together, MEDIK and STERIS will expand their offerings for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to strengthen its position as a leading provider of turnkey room solutions in surgical and IPT environments. The MEDIK management team will actively support the next phase of growth.

Learn more
Sunrise Eggs has been acquired by Agrova International
Private Equity | Agriculture | Food & Beverage

Sunrise Eggs has been acquired by Agrova International

Sunrise Eggs, one of the UK’s best-established independent egg producers and distributors, has joined Agrova International AS, a European poultry and agri-foods group.

Learn more